Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review.
Antiretroviral therapy
HIV
Hypertensive disorders of pregnancy
Preeclampsia
Pregnancy
cART
Journal
Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
21
12
2018
revised:
18
04
2019
accepted:
17
05
2019
pubmed:
6
9
2019
medline:
20
2
2020
entrez:
6
9
2019
Statut:
ppublish
Résumé
To assess if there is a relationship between use of combined antiretroviral therapy among pregnant women living with HIV and hypertensive disorders of pregnancy (HDP). Due to the heterogeneity of study designs in the literature and the utilization of different outcome measures in regards to assessing the presence of HDP, a systematic review was performed. ClinicalTrials.gov and MEDLINE, via PubMed, EMBASE, Scopus, CINAHL, ProQuest Dissertations & Theses Global, EBSCOHost, DARE, and the Cochrane Library, were queried from January 1997 to October 2017. Studies were included if they reported HDP and focused on pregnant women living with HIV who used combined antiretroviral therapy. The Cochrane Collaboration's tool for assessment of risk of bias and the U.S. Preventive Services Task Force grading scale were used to assess the studies. Of 1055 abstracts, 28 articles met inclusion criteria. The data are marked by multiple biases and poor study design. All studies demonstrate an increased risk of HDP among pregnant women living with HIV who used combined antiretroviral therapy when compared to seropositive pregnant women not using antiretroviral therapy. Three studies suggest protease inhibitors may be associated with a higher risk of HDP. Despite all studies indicating a higher frequency of HDP among pregnant women living with HIV using combined antiretroviral therapy when compared with seropositive pregnant women not using antiretroviral therapy, the quality of the studies is mixed, necessitating further research.
Identifiants
pubmed: 31487638
pii: S2210-7789(18)30766-9
doi: 10.1016/j.preghy.2019.05.015
pmc: PMC6733581
mid: NIHMS1532751
pii:
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
178-190Subventions
Organisme : NICHD NIH HHS
ID : K12 HD050121
Pays : United States
Organisme : NICHD NIH HHS
ID : K23 HD078153
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Informations de copyright
Copyright © 2019 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.
Références
Obstet Gynecol. 1999 Nov;94(5 Pt 1):641-6
pubmed: 10546703
Lancet. 2002 Oct 12;360(9340):1152-4
pubmed: 12387967
Br Med J. 1975 Mar 8;1(5957):548-9
pubmed: 124613
Lancet. 2003 Jan 25;361(9354):347-8
pubmed: 12559889
Eur J Obstet Gynecol Reprod Biol. 2004 Dec 1;117(2):240-1
pubmed: 15541864
AIDS. 2006 Jan 2;20(1):59-66
pubmed: 16327320
J Clin Nurs. 2006 Jun;15(6):735-41
pubmed: 16684169
AIDS. 2006 Sep 11;20(14):1823-31
pubmed: 16954723
BJOG. 2007 Feb;114(2):148-55
pubmed: 17305888
J Reprod Immunol. 2007 Dec;76(1-2):75-7
pubmed: 17568688
Am J Obstet Gynecol. 2008 Jan;198(1):7-22
pubmed: 18166297
Am J Obstet Gynecol. 2009 Feb;200(2):149.e1-5
pubmed: 18973871
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Am J Obstet Gynecol. 2009 Sep;201(3):315.e1-5
pubmed: 19733286
Placenta. 2010 Jun;31(6):512-8
pubmed: 20434767
Int J Gynaecol Obstet. 2011 Oct;115(1):20-5
pubmed: 21767835
J Obstet Gynaecol Can. 2012 Feb;34(2):136-141
pubmed: 22340062
PLoS One. 2012;7(2):e31580
pubmed: 22384039
J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):517-24
pubmed: 23344545
S Afr Med J. 2013 Jun 05;103(8):543-8
pubmed: 23885736
PLoS One. 2013 Oct 04;8(10):e74848
pubmed: 24124458
J Infect. 2014 Jun;68(6):572-80
pubmed: 24462561
J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):155-63
pubmed: 24562349
J Am Soc Hypertens. 2015 May;9(5):351-7
pubmed: 25766497
Pregnancy Hypertens. 2014 Jan;4(1):91-6
pubmed: 26104261
J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):91-8
pubmed: 26322669
Lancet. 2016 Mar 5;387(10022):999-1011
pubmed: 26342729
Int J Gynaecol Obstet. 2016 Apr;133(1):17-21
pubmed: 26797203
Obstet Gynecol. 2016 Jun;127(6):1027-32
pubmed: 27159742
Am J Obstet Gynecol. 2016 Oct;215(4):499.e1-8
pubmed: 27263995
Int J Gynaecol Obstet. 2016 Sep;134(3):304-8
pubmed: 27350229
Int J Gynaecol Obstet. 2016 Sep;134(3):299-303
pubmed: 27365290
Am J Obstet Gynecol. 2017 Feb;216(2):110-120.e6
pubmed: 27640943
Pregnancy Hypertens. 2016 Oct;6(4):266-268
pubmed: 27939465
Int J Gynaecol Obstet. 2017 Feb;136(2):195-199
pubmed: 28099739
Drugs. 2017 Nov;77(17):1819-1831
pubmed: 29039130